Sintilimab in Treating Advanced Lung Squamous Cell Carcinoma After Fourth-Line Treatment of Anlotinib Resistance.
American journal of therapeutics（2021）
摘要
Wu, Kai MM; Wei, Li MM; Fu, Yifan MM; Zeng, Daxiong MD; Wang, Changguo MD; Jiang, Junhong MD Author Information
更多查看译文
关键词
anlotinib resistance,squamous cell carcinoma,lung,fourth-line
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要